Novartis AG said it will buy a 52 percent stake in Alcon Inc., the world’s largest eye-care company, from Nestle SA for $28.1 billion as Chief Executive Officer Daniel Vasella expands into products for eye surgery.

See the original post here:
Novartis to Buy Nestle’s Alcon Stake for $28.1 Billion